Earnings
PTCT
42.95
-0.51%
-0.22
Currencies: USD
Items
Net Income
Depreciation and Amortization
Deferred Tax
Unamortized Expenditures
Accrued Expenses
Share-based Compensation
Assets Disposal
Financial Expenses
Investment Loss
Working Capital Change
Other Items
Operating Activities
Purchases of Fixed Assets
Proceeds from Disposal of Fixed Assets
Investment Expenditure
Investment Income
Other Investing Activities
Investing Activities
Issuance of Capital Stock
Issuance of Bonds
Proceeds from Borrowings
Dividend Payments
Repayment of Borrowings
Buyback Payments
Stock Incentive Compensation
Other Financing Activities
Financing Activities
Effect of Exchange Rate Changes 
Net Increase in Cash,Cash Equivalents
FY 2020-12-31
-438.16M
43.49M
5.87M
--
--
--
157.82M
--
--
36.91M
--
-194.07M
-17.84M
--
--
--
-543.71M
-561.55M
103.57M
-46.16M
--
--
--
--
--
--
668.72M
7.69M
-79.22M
FY 2019-12-31
-251.58M
32.18M
8.83M
--
--
--
91.50M
--
--
20.43M
--
-98.64M
-13.76M
--
--
--
-373.48M
-387.24M
345.61M
267.60M
--
--
--
--
--
--
613.21M
-1.30M
126.03M
FY 2018-12-31
-128.08M
26.09M
0.00
--
--
--
60.14M
--
--
14.21M
--
-27.64M
-7.10M
--
--
--
-35.52M
-42.61M
131.57M
0.00
--
--
--
--
--
--
131.57M
-3.61M
57.71M
FY 2017-12-31
-79.00M
17.68M
199.00K
--
--
--
37.83M
--
--
13.23M
--
-10.06M
-3.10M
--
--
--
16.22M
13.12M
4.65M
40.00M
--
--
--
--
--
--
44.22M
6.20M
53.47M
FY 2016-12-31
-142.11M
3.29M
-199.00K
--
--
--
44.42M
--
--
-8.96M
--
-103.57M
-1.78M
--
--
--
106.26M
104.48M
968.00K
0.00
--
--
--
--
--
--
968.00K
-1.58M
299.00K

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out PTCT latest annual and quarterly financial reports. There are also historical financial reports for you to reference. You can analyze PTC Therapeutics recent business situations by check its cash flow statements, balance sheets, income statements and other tables. Comprehensive data may help you to understand and analyze PTCT development prospects in various aspects, and this information may help you to better grasp the PTC Therapeutics operation.